Lymphatic filariasis in soldiers exposed in INDOPACOM
View abstract on PubMed
Summary
This summary is machine-generated.Military preventive chemotherapy for filariasis in the U.S. Indo-Pacific Command (INDOPACOM) is likely unnecessary. Historical data shows few clinical filariasis cases in soldiers, suggesting cessation of routine treatment.
Area Of Science
- Tropical Medicine
- Military Health
- Infectious Diseases
Background
- Lymphatic filariasis historically affected military personnel in the Pacific during WWII.
- Filariasis cases in U.S. service members were rare in Vietnam and Timor Leste.
- Mass drug administration has reduced filariasis prevalence in the INDOPACOM region.
Purpose Of The Study
- To review the historical basis for presumptive filariasis treatment in U.S. military organizations within INDOPACOM.
- To evaluate the current necessity of preventive chemotherapy for filariasis in deployed soldiers.
Main Methods
- Historical review of clinical filariasis cases among military personnel in various Pacific and Southeast Asian conflicts.
- Analysis of epidemiological data on filariasis in U.S. and Australian soldiers.
- Assessment of filariasis prevalence post-mass drug administration in the INDOPACOM region.
Main Results
- Clinical filariasis was documented in U.S. Marines in Polynesia during WWII.
- Few filariasis cases were reported among U.S. and Australian soldiers in Melanesia, Vietnam, and Timor Leste.
- Recent deployments show rare seroconversions but no clinical filariasis, especially after mass drug administration.
Conclusions
- Presumptive filariasis treatment for returning soldiers in INDOPACOM may no longer be warranted.
- Reduced disease exposure due to mass drug administration supports cessation of preventive chemotherapy.
- Future military health strategies should consider the declining risk of filariasis in the region.

